To study the efficacy of Dhatryadi kwath and Vasadi kwath in management of Vatarakta (Gout).

Phase 3

• Conditions: Health Condition 1: M1A9- Chronic gout, unspecified

• Registration Number: CTRI/2023/08/056963
• Lead Sponsor: Vd Ravindra Namdev Sagbhor

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 September 2023

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Patient having signs and symptoms of vatarakta like shotha,kathinya,vedanadhikya,daha,Tod,shyavata/tamrata,spuran.

Patient of any sex, religion and socio-economic status.

2.newly diagnosed patient.

3.Patient with serum uric acid >7mg/dl in male and 6mg/dl in female.

Exclusion Criteria

1.Pathophysiology or genetic syndrome associated with vatarakta.

2.patient in serious symptoms like paak,khanja,pangulya and sandhivakrata are excluded.

3 malignancy, poorly controlled DM,HTN.

4.symptomatic patient with clinical evidence of heart failure.

5.complicated patient having target organ damage.

6.alcoholic and drug abusers, pregnant and lactating women.

Study & Design

• Study Type: Interventional
• Study Design: Not specified